UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000026749 |
|---|---|
| Receipt number | R000030706 |
| Scientific Title | assesment of newly developed discharge support system for the patients of hematological disorder |
| Date of disclosure of the study information | 2018/04/20 |
| Last modified on | 2017/03/29 00:20:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
assesment of newly developed discharge support system for the patients of hematological disorder
Acronym
assesment of newly developed discharge support system for the patients of hematological disorder
Scientific Title
assesment of newly developed discharge support system for the patients of hematological disorder
Scientific Title:Acronym
assesment of newly developed discharge support system for the patients of hematological disorder
Region
| Japan |
Condition
Condition
Hematology and clinical oncology
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
This study is aimed to develop the new system supporting early discharge from hospital for the patiens with hematological disorder.
Basic objectives2
Others
Basic objectives -Others
Scondary objective is to develop the system enabling medical staff to share the patients' infromation easiliy and rapidly
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Primary outcome is the number of hospitalization days and degree of satisfaction with or without newly developed discharge support system.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
expanded access
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
I conduct surveys on it by a survey by questionnaire and a group interview, and a leaving support tool is made and introduced, and its effect is considered from a survey by questionnaire and a group interview.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Because I find a problem and a reform measure and cooperate, and it's possible to support it with conducting surveys on it to a patient, a doctor of the family and a nurse actually when conducting leaving support in a ward actually.
Key exclusion criteria
I don't have that.
Target sample size
25
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | yukari nisiuchi |
Organization
University Hospital Kyoto Prefectural University of Medicine
Division name
B8
Zip code
Address
465, Kajiicho where I go up Kamigyo-ku, Kyoto-shi Kawahara-cho expert Hirokoji
TEL
075-251-5778
bobnaomi@koto.kpu-m.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | noriko hirota |
Organization
University Hospital Kyoto Prefectural University of Medicine
Division name
B8
Zip code
Address
465, Kajiicho where I go up Kamigyo-ku, Kyoto-shi Kawahara-cho expert Hirokoji
TEL
075-251-5778
Homepage URL
bobnaomi@koto.kpu-m.ac.jp
Sponsor or person
Institute
University Hospital Kyoto Prefectural University of Medicine
Institute
Department
Personal name
Funding Source
Organization
University Hospital Kyoto Prefectural University of Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 04 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2017 | Year | 02 | Month | 15 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 04 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 03 | Month | 29 | Day |
Last modified on
| 2017 | Year | 03 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030706
